Meeting Chair: Deputy Director of FDP

Members present

• Head of Information Governance, FDP
• Programme Director, FDP
• Portfolio Director, Data and Analytics Principal Accountant
• Regional Director of Digital Transformation – East of England Director of Transformation and Quality Improvement
• Director of Delivery – National Cancer Programme
• Deputy Director, Product Development and Implementation Senior Comms Lead
• Senior Governance Secretariat Officer, PMO
• Corporate Compliance and Governance Manager, PMO

Apologies

• Chair, Director of Data and Analytics / Deputy CDAO
• Director of Data Management and Transformation
• Director of Digital Operations and Innovation
• Director – Data and Analytics, Transformation
• Medical Productivity Director
• Commercial Director
• Chief Medical Officer
• Deputy Managing Director
• Assistant Head of Communications
• Regional Chief Operating Officer – Midlands Joint Chief Digital Officer
• Director of Out of Hospital UEC
• Executive Director, Strategy Change and In-Hospital Services
• Director of Privacy, Transparency and Ethics
• Programme Management Director
• Director of Privacy, Transparency and Ethics
• Director of Advanced Analysis, Data and Analytics
• Chief Technology Officer
• Director of Elective Recovery
• Assistant Director – Data Governance and Assurance
• Director of UEC Delivery
  Director of Delivery
• Director, National Health and Social Care Discharge Taskforce
• National Medical Director for Secondary Care

Welcome, introductions and declarations of interest

The Chair opened the meeting and noted that she would be deputising in the absence of the substantive Chair and Director of Data Management and Transformation.

Apologies for absence were noted. There were no declarations of interest.

Review of minutes and actions

The minutes from the Programme Board meeting held on Thursday 30 March were reviewed and approved.

The Board noted that both actions had been closed, with the discussion on FDP product integration included on the agenda and the PDG paper on Social Enterprises circulated in advance of the meeting.

Decisions made: Programme Delivery Group (PDG)

The Chair highlighted key decisions escalated from PDG.

2025/26 big wins and strategic outcome based objectives for 20226/27

The Chair outlined key achievements delivered during 2025/26 and the programme’s
confirmed strategic outcome-based objectives.

Members welcomed the programme’s progress across priority pathways and discussed the importance of balancing continued product development with deeper product adoption and benefits realisation.

Action: Provide a more detailed overview of the product progress

Programme highlights and FDP in numbers

An update was provided on programme highlights and operational metrics for March 2026.

Members discussed the presentation of KPI information and requested clearer operational and regional perspectives to support interpretation.

The Board noted that work was underway to refresh the KPI dashboard to improve clarity, visual presentation and articulation of programme impact.

Programme risk summary

An updated consolidated programme risk summary was presented.

Action: Improve risk reporting narrative, including risk movements and key supporting information.

Communications and engagement update

An update was provided on communications and engagement activity, including media interest, parliamentary activity and ongoing responses to Parliamentary Questions, Freedom of Information requests and media enquiries.

The Board noted that updated FAQs and communications materials were being developed to strengthen communications support.

Action: Develop clearer communications materials and FAQs explaining the relationship between FDP and the wider multi-supplier model, including clarification on data ownership.

Demand and delivery update

An update was provided on recent demand and delivery activity across the programme.

Product update

An update was provided on recent product developments, including the general availability of the Shared Patient Tracking List (PTL) and certification of the AI Assisted Discharge Summary (AADS) product as a Class I medical device.

The Board noted the continued emphasis on governance, assurance and trust in product rollout.
FDP Product Integration Update

The Board received an update on FDP product integration and the programme’s shift towards
converged, workflow-based solutions rather than standalone products.

Members noted the alignment between FDP products and wider national pathways and initiatives, with an emphasis on supporting integrated operational workflows and presenting a more joined-up national offer to providers.

The Board supported the direction of travel and noted the importance of effective integration and embedded workflows to improve adoption and reduce operational burden on providers.

Any other business

Members discussed how FDP could further align with evolving national and regional performance oversight arrangements, particularly in supporting challenged providers.

The programme team confirmed that ongoing work remained focused on capability building, knowledge transfer and sustainable transformation.

Completed by: FDP PMO Reviewed by: FDP PMO
Confirmed by: Director of Data Management and Transformation